Chilean guideline for budget impact analysis

Tags: Poster
Rubilar-González M1, Hurtado V1, de la Puente C1, Poblete S1, Vera F1, Kuhn L1, Araya F1
1Ministerio de Salud Chile

Background: once the coverage decision has been made by the authority, it is necessary to financially appraise the impact of the introduction of this new alternative available to patients. This estimation is made through a budget impact analysis (BIA). Despite being a daily use methodology, the Ministry of Health did not have a guide to explain how to carry out this analysis, this was the motivation to create a budget impact analysis guide of health interventions for the Ministry of Health of Chile.

Objectives: establish a methodological framework and guidelines that serve as a reference for different audiences for the design and development of a BIA for health interventions in Chile.

Methods: we developed a systematic review of the literature of methodological articles and a review in international health technology assessment agencies. We extracted data from the selected articles according to the established template, from both methodological articles and international guidelines. Subsequently, we discussed the extracted information, which we categorized according to the main aspects of a BIA. Based on this, we built the draft guide, and submitted this document to public consultation to receive comments. After the comments had been discussed, we developed the final document. In addition, we designed an electronic spreadsheet and procedural documents to support the development of the BIA.

Results: we identified 349 articles, selecting 11 by titles and abstracts. Our manual search added a further 24 articles. From the full-text review, we selected 20 articles for data extraction. Finally, we built the guide, along with an electronic spreadsheet and procedural documents to perform the BIA in order to ensure reliability and ensure transparency.

Conclusions: this guide will strengthen decision making, reducing methodological variability, promoting transparency and ensuring the reliability of this type of analysis.

Patient or healthcare consumer involvement: in order to involve a diversity of stakeholders (as patients and patient’s relatives) we submitted a public consultation during the guide preparation. Feedback, concerns, and questions were provided by patients, which we included in the final version of the document. Therefore, this participation of relevant actors ensures the guide fits the real needs of the population regarding assessing medicines and treatments, also enhancing the transparency of the procedure.